Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The researchers found that among adults who were overweight or obese who completed the 20-week run-in period with subcutaneous semaglutide, maintaining treatment with semaglutide resulted in continued weight loss over the following 48 weeks compared to switching to placebo
The 6-month wait is outdated and harmful : Current guidelines requiring 6 months of behavioral therapy before medication lead to high dropout rates (53-70% of early non-responders fail to achieve 5% weight loss) and treatment abandonment
GoMed Singapore , a Singapore licensable outpatient medical service provider, our doctors provide online consultations for eligible patients seeking medically guided weight management support through personalised, doctor-led care
doi: 10.1007/s00125-006-0468-0 12 FribergEOrsiniNMantzorosCSWolkA
